RIM
BMY icon

Rainier Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Rainier Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-48,350
Closed -$2.83M – 155
2016
Q4 		$2.83M Sell
48,350
-112,200
-70% -$6.13M 0.28% 132
2016
Q3 		$8.66M Sell
160,550
-20,460
-11% -$1.31M 0.56% 79
2016
Q2 		$13.3M Buy
+181,010
New +$12.8M 0.64% 62

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rainier Investment Management's BMY Position: Q1 2017 in Review

Rainier Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 48,350 shares — an estimated $2.83M sold.

Rainier Investment Management first reported a position in BMY in Q2 2016 and held it in 3 quarters. The position peaked at $13.3M in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Rainier Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
  • Rainier Investment Management sold 48,350 Bristol-Myers Squibb shares in Q1 2017, an estimated $2.83M.
  • Rainier Investment Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 3 quarters.
  • Rainier Investment Management's Bristol-Myers Squibb position peaked at $13.3M in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Rainier Investment Management's 13F filing for Q1 2017, filed 12 May 2017.